ENTITY
Sysmex

Sysmex (6869 JT)

6
Analysis
Health Care • Japan
SYSMEX CORPORATION manufactures reagents and equipment for clinical tests including hematologic (blood) and immune tests. The Company also develops, manufactures, and trades particle analyzers such as blood coagulation analyzer and related software. Manufacturing and sales outside Japan include the United States, EMEA, China and Asia Pacific regions.
more
•04 Mar 2017 11:12

The Week That Was in NorthAsia@Smartkarma - Jelly Drinks, Dental Implants, & Tires

This is the inaugural report of "The Week That Was in North Asia@Smartkarma. This is a collaborative report among Travis Lundy, Mio Kato, CFA,...

Logo
446 Views
Share
•30 Jan 2017 13:50

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

AML represents one of the largest hematologic cancer populations with one of the worst survival rates. Global prevalence is expected to increase at...

bearish•Sysmex
•21 Apr 2026 05:40

Sysmex (6869 JP): Positioned for Global Index Deletion

Sysmex is a potential delete from a global index in May. The stock has underperformed peers and trades cheaper. There is positioning in the stock....

Logo
397 Views
Share
•13 Dec 2016 11:44

American Society of Hematology- (ASH) Annual Conference (2016) Review

We reviewed data presented at the American Society of Hematology (ASH) conference in San Diego last week with a focus on the evolving treatment...

•03 Dec 2016 18:43

American Society of Hematology (ASH) -Annual Conference (2016) Preview

With a focus on novel mechanisms of action (MoA), we highlight select non-Hodgkin's lymphoma (NHL) and Multiple Myeloma (MM) related abstracts at...

x